Cargando…

Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis

Rheumatoid arthritis (RA) management has greatly improved with the development of biologic disease modifying antirheumatic drugs, but a proportion of patients do not improve despite the biologic drugs currently available. We need new biologic agents with novel mechanisms of action for the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Franco, Manuela, Gerardi, Maria Chiara, Lucchino, Bruno, Conti, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958547/
https://www.ncbi.nlm.nih.gov/pubmed/24648832
http://dx.doi.org/10.2147/CE.S39770